NCT06959992 Developing Resilience in Transgender and Nonbinary Individuals - Exploring the Impact of Social Challenges in the Metaverse
| NCT ID | NCT06959992 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Bucharest |
| Condition | Resilience,Psychological |
| Study Type | INTERVENTIONAL |
| Enrollment | 123 participants |
| Start Date | 2025-09-01 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 123 participants in total. It began in 2025-09-01 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this clinical trial is to test the effectiveness of conducting a support group in the Metaverse designed to develop and/or improve resilience in gender diverse people. By exploring the impact of different social challenges in a virtual environment, the main question it aims to answer is whether this approach on conducting support group sessions with gender diverse people will strengthen their resilience and associated abilities (self-compassion) compared to a control group and a waitlist.
Eligibility Criteria
Inclusion Criteria: * Transgender and nonbinary individuals with a stable gender-identity or questioning Exclusion Criteria: * Presence of acute psychiatric instability (e.g., acute psychotic symptomatology or acute suicide risk) * Not being part of the transgender population * Younger than 18
Contact & Investigator
Cezar Giosan, PhD
PRINCIPAL INVESTIGATOR
University of Bucharest
Frequently Asked Questions
Who can join the NCT06959992 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 35 Years, studying Resilience,Psychological. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06959992 currently recruiting?
Yes, NCT06959992 is actively recruiting participants. Contact the research team at giosan@outlook.com for enrollment information.
Where is the NCT06959992 trial being conducted?
This trial is being conducted at Bucharest, Romania.
Who is sponsoring the NCT06959992 clinical trial?
NCT06959992 is sponsored by University of Bucharest. The principal investigator is Cezar Giosan, PhD at University of Bucharest. The trial plans to enroll 123 participants.